| 000 | 00715nam a2200217Ia 4500 | ||
|---|---|---|---|
| 005 | 20260808125443.0 | ||
| 008 | 260808s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a(0195-7996) | ||
| 035 | _a5205 | ||
| 041 | _aENG | ||
| 082 | _a615.11 | ||
| 100 | _aUnited States Pharmacopeial Convention Inc | ||
| 245 | 0 |
_aUnited State pharmacopoeia xxi _bsupplement 1 (the national formulary) |
|
| 250 | _a16th | ||
| 260 |
_aRockville _bUnited State Pharmacopeial Convention Incorporation _c1985 |
||
| 300 | _a1685 - 1787 | ||
| 500 | _aC/1472 / 01.04.1985 | ||
| 505 | _aUSP, United States Pharmacopoeia, drug standards, pharmaceutical reference | ||
| 650 |
_aReferences (USP) _bPharmacology -- Therapeutics |
||
| 942 | _cBK | ||
| 999 |
_c5203 _d5203 |
||